Reuters logo
BRIEF-AstraZeneca exec: $3.5 bln Brilinta sales goal no longer attainable
2016年10月4日 / 早上7点21分 / 1 年前

BRIEF-AstraZeneca exec: $3.5 bln Brilinta sales goal no longer attainable

Oct 4 (Reuters) - AstraZeneca Plc

* Executive Ludovic Helfgott tells Reuters $3.5 billion sales goal for Brilinta no longer attainable Further company coverage: (Reporting by UK bureau)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below